HPV for cervical cancer screening (HPV FOCAL): complete round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249 · see citing works

International Agency for Research on Cancer (IARC)

(2018) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-94186-5_629 · Cited by 2,796 · see citing works

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810 · see citing works

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 935 · see citing works

The cervical cancer epidemic that screening has prevented in the UK

Peto, J., Gilham, C., Fletcher, O., & Matthews, F. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16674-9 · Cited by 809 · see citing works

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797 · see citing works

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

Saslow, D., Solomon, D., Lawson, H. W., Killackey, M. A., Kulasingam, S., Cain, J. M., García, F., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 790 · see citing works

A review of clinical trials of human papillomavirus prophylactic vaccines

Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747 · see citing works

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

Bulkmans, N. W. J., Berkhof, J. H., Rozendaal, L., van Kemenade, F. J., Boeke, A. J. P., Bulk, S., Voorhorst, F. J., Verheijen, R. H. M., van Groningen, K., Boon, M. E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61450-0 · Cited by 636 · see citing works

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

Wright, T. C., Stoler, M. H., Behrens, C. M., Sharma, A., Zhang, G., & Wright, T. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.11.076 · Cited by 601 · see citing works

Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors

Vaccarella, S., Lortet‐Tieulent, J., Plummer, M., Franceschi, S., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.024 · Cited by 499 · see citing works

Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance

Huh, W. K., Ault, K. A., Chelmow, D. P., Davey, D. D., Goulart, R. A., García, F., Kinney, W., Massad, L. S., Mayeaux, E. J., Saslow, D., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.022 · Cited by 492 · see citing works

A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica

Castle, P. E., SCHIFFMAN, M. H., Herrero, R., Hildesheim, A., Rodríguez, A. C., Bratti, M. C., Sherman, M. E., Wacholder, S., Tarone, R. E., & Burk, R. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/428779 · Cited by 404 · see citing works

Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions

Steenbergen, R. D. M., Snijders, P. J. F., Heideman, D. A. M., & Meijer, C. J. L. M. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3728 · Cited by 394 · see citing works

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

Kitchener, H. C., Almonte, M., Thomson, C., Wheeler, P., Sargent, A., Stoykova, B., Gilham, C., Baysson, H., Roberts, C., Dowie, R., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70156-1 · Cited by 390 · see citing works

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A., Gillison, M. L., Doorbar, J., Stern, P. L., Stanley, M., Arbyn, M., Poljak, M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.003 · Cited by 330 · see citing works

Human papillomavirus in a necessary cause of invasive cervical cancer worldwide

(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140 · see citing works

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus

Kash, N., Lee, M., Kollipara, R., Downing, C. P., Guidry, J. A., & Tyring, S. K. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4040614 · Cited by 120 · see citing works

Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none

El‐Zein, M., Richardson, L., & Franco, E. L. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.11.020 · Cited by 107 · see citing works

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study

Ogilvie, G. S., Krajden, M., van Niekerk, D. J., Martin, R. E., Ehlen, T. G., Ceballos, K. M., Smith, L., Kan, L., Cook, D. A., Peacock, S. J., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.489 · Cited by 84 · see citing works

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)

Ogilvie, G. S., van Niekerk, D. J., Krajden, M., Martin, R. E., Ehlen, T. G., Ceballos, K. M., Peacock, S. J., Smith, L., Kan, L., Cook, D. A., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-111 · Cited by 84 · see citing works

Use of Cytology, E6/E7 mRNA, and p16 INK4a –Ki-67 to Define the Management of Human Papillomavirus (HPV)–Positive Women in Cervical Cancer Screening

Gustinucci, D., Rossi, P. G., Cesarini, E. N., Broccolini, M., Bulletti, S., Carlani, A., D’angelo, V., D’amico, M. R., Dato, E. D., Galeazzi, P., et al. (2015) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqv019 · Cited by 59 · see citing works

FDA approves new upgraded Gardasil 9

Kirby, T. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71191-x · Cited by 54 · see citing works

Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3

Kotaniemi‐Talonen, L., Anttila, A., Malila, N. K., Tarkkanen, J., Laurila, P., Hakama, M., & Nieminen, P. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.12.002 · Cited by 54 · see citing works

A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years

Rebolj, M., Bonde, J. H., Ejegod, D. M., Preisler, S., Rygaard, C., & Lynge, E. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.04.012 · Cited by 26 · see citing works

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada

Ogilvie, G. S., Cook, D. A., Taylor, D. L., Rank, C., Kan, L., Yu, A. M., Mei, W., van Niekerk, D. J., Coldman, A. J., & Krajden, M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.085 · Cited by 23 · see citing works

Transitioning to a new era in cervical cancer screening

SCHIFFMAN, M. H., & Wentzensen, N. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.538 · Cited by 12 · see citing works

New standard of care—HPV testing for cervical cancer screening

Castle, P. E. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.37 · Cited by 6 · see citing works

Review of Peter Taylor et al., Global Urban Analysis: A Survey of Cities in Globalization

Smith, D. A. (2015) · Journal of World-Systems Research · doi:10.5195/jwsr.2015.33 · Cited by 1 · see citing works

Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.10897 · Cited by 1,409 · see citing works

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30068-4 · Cited by 943 · see citing works

Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing

Melnikow, J. A., Henderson, J. T., Burda, B. U., Senger, C. A., Durbin, S., & Weyrich, M. S. (2018) · JAMA · doi:10.1001/jama.2018.10400 · Cited by 326 · see citing works

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months

Ogilvie, G. S., van Niekerk, D., Krajden, M., Smith, L., Cook, D. A., Gondara, L., Ceballos, K. M., Quinlan, D., Lee, M. H., Martin, R. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.7464 · Cited by 283 · see citing works

Primary HPV screening for cervical cancer

Bhatla, N., & Singhal, S. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.02.008 · Cited by 235 · see citing works

Screening for Cervical Cancer in Primary Care

Kim, J. J., Burger, E. A., Regan, C., & Sy, S. (2018) · JAMA · doi:10.1001/jama.2017.19872 · Cited by 170 · see citing works

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm

Tota, J. E., Bentley, J., Blake, J. M., Coutlée, F., Duggan, M. A., Ferenczy, A. S., Franco, E. L., Fung‐Kee‐Fung, M., Gotlieb, W. H., Mayrand, M., et al. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2016.11.029 · Cited by 114 · see citing works

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J. M. L., Gertig, D. M., Jennett, C. J., Farnsworth, A., Tan, J., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002388 · Cited by 100 · see citing works

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial

Cook, D. A., Krajden, M., Brentnall, A. R., Gondara, L., Chan, T., Law, J. H., Smith, L., van Niekerk, D. J., Ogilvie, G. S., Coldman, A. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31976 · Cited by 84 · see citing works

Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention

Gradíssimo, A., & Burk, R. D. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1293525 · Cited by 83 · see citing works

Cervical cytology screening facilitated by an artificial intelligence microscope: A preliminary study

Tang, H., Cai, D., Kong, Y., Hu, Y., Ma, Z., Lv, H., Tuo, L., Pan, Q., Liu, Z., & Han, X. (2021) · Cancer Cytopathology · doi:10.1002/cncy.22425 · Cited by 56 · see citing works

“The best thing is that you are doing it for yourself” – perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study

Bakiewicz, A., Rasch, V., Mwaiselage, J. D., & Linde, D. S. (2020) · BMC Women s Health · doi:10.1186/s12905-020-00917-7 · Cited by 49 · see citing works

Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study

Zhao, Y., Bao, H., Ma, L., Song, B., Di, J., Wang, L., Gao, Y., Ren, W., Shi, W., Wang, H., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02026-0 · Cited by 50 · see citing works

Barriers to cervical cancer screening and acceptability of HPV self-testing: a cross-sectional comparison between ethnic groups in Southern Thailand

Gottschlich, A., Nuntadusit, T., Zarins, K. R., Hada, M., Chooson, N., Bilheem, S., Navakanitworakul, R., Nittayaboon, K., Virani, S., Rozek, L. S., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031957 · Cited by 46 · see citing works

Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies

Sawaya, G. F., Sanstead, E. C., Alarid‐Escudero, F., Smith‐McCune, K., Gregorich, S. E., Silverberg, M. J., Leyden, W. A., Huchko, M. J., Kuppermann, M., & Kulasingam, S. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0299 · Cited by 43 · see citing works

Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology

Gustavsson, I. M., Aarnio, R., Berggrund, M., Hedlund‐Lindberg, J., Strand, A.-S., Sanner, K., Wikström, I., Enroth, S., Olovsson, M., & Gyllensten, U. B. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.485 · Cited by 42 · see citing works

Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening

Tota, J. E., Bentley, J., Blake, J. M., Coutlée, F., Duggan, M. A., Ferenczy, A. S., Franco, E. L., Fung‐Kee‐Fung, M., Gotlieb, W. H., Mayrand, M., et al. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2016.11.030 · Cited by 39 · see citing works

Cervical Cancer Screening

Sawaya, G. F., & Huchko, M. J. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.03.006 · Cited by 38 · see citing works

Empowering the on-site detection of nucleic acids by integrating CRISPR and digital signal processing

Lee, C. Y., Kim, H., Degani, I., Lee, H., Sandoval, A., Nam, Y., Pascavis, M., Park, H. G., Randall, T. C., Ly, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50588-3 · Cited by 37 · see citing works

Benefits and potential harms of human papillomavirus (HPV)‐based cervical cancer screening: A real‐world comparison of HPV testing versus cytology

Thomsen, L. T., Kjær, S. K., Munk, C., Ørnskov, D., & Waldstrøm, M. (2021) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.14121 · Cited by 36 · see citing works

Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations

Gates, A., Pillay, J., Reynolds, D. L., Stirling, R., Traversy, G., Korownyk, C. S., Moore, A. E., Thériault, G., Thombs, B. D., Little, J., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-020-01538-9 · Cited by 31 · see citing works

Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy

Carobeli, L. R., Meirelles, L. E. D. F., Damke, G. M. Z. F., Damke, E., de Souza, M. V. F., Mari, N. L., Mashiba, K. H., Mesquita, C. S. S., Souza, R. P., da Silva, V. R. S., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122057 · Cited by 30 · see citing works

Analysis of HPV distribution in patients with cervical precancerous lesions in Western China

Li, K., Yin, R., Li, Q., & Wang, D. (2017) · Medicine · doi:10.1097/md.0000000000007304 · Cited by 30 · see citing works

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial

Cook, D. A., Smith, L., Law, J. H., Mei, W., Gondara, L., van Niekerk, D. J., Ceballos, K. M., Jang, D., Chernesky, M., Franco, E. L., et al. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.09.004 · Cited by 29 · see citing works

Cervico-Vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: high acceptability, hrHPV diversity and risk factors

Rodrigues, L. L. S., Morgado, M. G., Sahasrabuddhe, V. V., De Paula, V. S., Oliveira, N. S., Chavez-Juan, E., Da Silva, D. M., Kast, W. M., Nicol, A. F., & Pilotto, J. H. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.08.004 · Cited by 29 · see citing works

Predictive Value of HPV Testing in Self-collected and Clinician-Collected Samples Compared with Cytology in Detecting High-grade Cervical Lesions

El‐Zein, M., Bouten, S., Louvanto, K., Gilbert, L., Gotlieb, W. H., Hemmings, R., Behr, M. A., Franco, E. L., & the CASSIS Study Group* (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1338 · Cited by 29 · see citing works

Label-free and dual-mode biosensor for HPV DNA based on DNA/silver nanoclusters and G-quadruplex/hemin DNAzyme

Chen, J., Wang, M., Zhou, C., Zhang, J., & Su, X. (2022) · Talanta · doi:10.1016/j.talanta.2022.123554 · Cited by 28 · see citing works

Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing

Thompson, E. L., Galvin, A. M., Daley, E. M., Tatar, O., Zimet, G. D., & Rosberger, Z. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105928 · Cited by 27 · see citing works

Primary HPV testing with cytology versus cytology alone in cervical screening—A prospective randomized controlled trial with two rounds of screening in a Chinese population

Chan, K. K. L., Liu, S. S., Wei, N., Ngu, S., Chu, M. M. Y., Tse, K. Y., Lau, L. S. K., Cheung, A., & Ngan, H. (2020) · International Journal of Cancer · doi:10.1002/ijc.32861 · Cited by 26 · see citing works

High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa

Chachage, M., Parikh, A. P., Mahenge, A., Bahemana, E., Mnkai, J., Mbuya, W., Mcharo, R. D., Maganga, L., Mwamwaja, J., Gervas, R. R., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003437 · Cited by 28 · see citing works

Acceptability of Self-Sample Human Papillomavirus Testing Among Thai Women Visiting a Colposcopy Clinic

Phoolcharoen, N., Kantathavorn, N., Krisorakun, W., Taepisitpong, C., Krongthong, W., & Saeloo, S. (2018) · Journal of Community Health · doi:10.1007/s10900-017-0460-2 · Cited by 24 · see citing works

Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort

Gottschlich, A., van Niekerk, D., Smith, L., Gondara, L., Melnikow, J. A., Cook, D. A., Lee, M. H., Stuart, G. C. E., Martin, R. E., Peacock, S. J., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1177 · Cited by 25 · see citing works

A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15‐year cervical cancer screening experience at Kaiser Permanente Northern California

Hammer, A., Demarco, M., Campos, N. G., Befano, B., Gravitt, P. E., Cheung, L. C., Lorey, T. S., Poitras, N. E., Kinney, W., Wentzensen, N., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32950 · Cited by 22 · see citing works

Screening for Cervical Cancer: A Comprehensive Review of Guidelines

Zampaoglou, E., Boureka, E., Gounari, E., Liasidi, P.-N., Kalogiannidis, I. A., Tsimtsiou, Z., Haidich, A., Tsakiridis, I. G., & Dagklis, T. (2025) · Cancers · doi:10.3390/cancers17132072 · Cited by 23 · see citing works

Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer

Zhu, S., Zhu, J., Song, Y., Chen, J., Wang, L., Zhou, M., Jiang, P., Li, W., Xue, X., Zhao, K., et al. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9167-2 · Cited by 21 · see citing works

HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study

Andersen, B. S., Njor, S. H., Jensen, A. M. S., Johansen, T. O., Jeppesen, U., & Svanholm, H. (2020) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-001457 · Cited by 23 · see citing works

Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women

Jiang, M., Wu, Z., Li, T., Yu, L., Zhang, S., Zhang, X., Qu, P., Sun, P., Xi, M., Liu, X., et al. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0144 · Cited by 19 · see citing works

Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage

Yu, L., Jiang, M., Qu, P., Wu, Z., Sun, P., Xi, M., Yu, Q., Liu, X., Liao, G., Lei, X., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31368 · Cited by 19 · see citing works

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer ( HPV FOCAL ) trial

Gottschlich, A., Gondara, L., Smith, L., Cook, D. A., Martin, R. E., Lee, M. H., Peacock, S. J., Proctor, L., Stuart, G. C. E., Krajden, M., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34039 · Cited by 19 · see citing works

Primary HPV cervical cancer screening in the United States: Are we ready?

Nayar, R., Goulart, R. A., & Davey, D. D. (2017) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2017.12.001 · Cited by 18 · see citing works

Changes in rate and socioeconomic inequality of cervical cancer screening in northeastern China from 2013 to 2018

Liu, Y., Guo, J., Zhu, G., Zhang, B., & Feng, X. L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913361 · Cited by 17 · see citing works

High‐risk HPV testing vs liquid‐based cytology for cervical cancer screening among 25‐ to 30‐year‐old women: A historical cohort study

Feldstein, O., Gali‐Zamir, H., Schejter, E., Feinberg, T., Yehuda‐Shnaidman, E., Bornstein, J., & Levy, T. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14482 · Cited by 21 · see citing works

High sensitivity and specificity rates of cobas® HPV test as a primary screening test for cervical intraepithelial lesions in a real-world setting

Fleider, L. A., Tinnirello, M. D. L. Á., Cherey, F. G., García, M. G. N., Cardinal, L., Kamermann, F. G., & Tatti, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279728 · Cited by 16 · see citing works

Long-term cervical precancer outcomes after a negative DNA- or RNA-based human papillomavirus test result

Strang, T. H. R., Gottschlich, A., Cook, D. A., Smith, L., Gondara, L., Franco, E. L., van Niekerk, D. J., Ogilvie, G. S., & Krajden, M. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.05.038 · Cited by 16 · see citing works

Women’s acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results

Smith, L., Racey, C. S., Gondara, L., Krajden, M., Lee, M. H., Martin, R. E., Stuart, G. C. E., Peacock, S. J., Coldman, A. J., Franco, E. L., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052084 · Cited by 16 · see citing works

Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology

Barroeta, J. E., Adhikari‐Guragain, D., & Grotkowski, C. E. (2017) · Diagnostic Cytopathology · doi:10.1002/dc.23737 · Cited by 15 · see citing works

Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial

Cromwell, I., Smith, L., van der Hoek, K., Hedden, L., Coldman, A. J., Cook, D. A., Franco, E. L., Krajden, M., Martin, R. E., Lee, M. H., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3864 · Cited by 15 · see citing works

Comparative analysis of HPV testing versus cytology in Danish cervical cancer screening: Insights from a large-scale implementation study

Lindquist, S., Kjær, S. K., Frederiksen, K., Ørnskov, D., Munk, C., & Waldstrøm, M. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.09.013 · Cited by 14 · see citing works

Human Papillomavirus-Associated Tumor Extracellular Vesicles in HPV+ Tumor Microenvironments

Gameiro, S. F., & Flondra, K. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175668 · Cited by 13 · see citing works

HPV screening, invasive cervical cancer and screening policy in Australia

Cox, B., & Sneyd, M. J. (2018) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2018.07.003 · Cited by 13 · see citing works

Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education

Andersson, S., Belkic, K. L., Mints, M., & Östensson, E. (2019) · Journal of Cancer Education · doi:10.1007/s13187-019-01608-0 · Cited by 13 · see citing works

Screening for the prevention and early detection of cervical cancer: systematic reviews to inform an update to recommendations by the Canadian Task Force on Preventive Health Care

Pillay, J., Gates, A., Guitard, S., Zakher, B., Sim, S., Vandermeer, B. W., & Hartling, L. (2025) · Systematic Reviews · doi:10.1186/s13643-025-02866-4 · Cited by 13 · see citing works

Cervical screening in HPV-vaccinated populations

Canfell, K. (2018) · Climacteric · doi:10.1080/13697137.2018.1428296 · Cited by 12 · see citing works

HPV Testing and its Role in Cervical Cancer Screening

Clarke, M. A. (2023) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000793 · Cited by 11 · see citing works

Evaluation of an Isothermal Amplification HPV Assay on Self-Collected Vaginal Samples as Compared to Clinician-Collected Cervical Samples

Chan, A. H. Y., Ngu, S., Lau, L. S. K., Tsun, O. K. L., Ngan, H., Cheung, A., & Chan, K. K. L. (2023) · Diagnostics · doi:10.3390/diagnostics13213297 · Cited by 11 · see citing works

Prevalence of high‐risk HPV among marginalized urban women in India and its implications on vaccination: A cross sectional study

Vora, K. S., Saiyed, S., Joshi, R., & Natesan, S. (2022) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14428 · Cited by 11 · see citing works

Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study

Gottschlich, A., Gondara, L., Smith, L., Anderson, J. J., Cook, D. A., Krajden, M., Lee, M. H., Martin, R. E., Melnikow, J. A., Peacock, S. J., et al. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100598 · Cited by 12 · see citing works

Preparation and Properties of a Low Fouling Magnetic Nanoparticle and Its Application to the HPV Genotypes Assay in Whole Serum

Chen, L., Liu, M., Tang, Y., Chen, C., Wang, X., & Hu, Z. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b04147 · Cited by 11 · see citing works

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology

Kong, T., Kim, M., Kim, Y. H., Kim, Y. B., Kim, J., Kim, J., Park, M. H., Park, J. H., Rhee, J. H., Lim, M. C., et al. (2019) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2020.31.e31 · Cited by 11 · see citing works

Agreement of self- and physician-collected samples for detection of high-risk human papillomavirus infections in women attending a colposcopy clinic in Thailand

Phoolcharoen, N., Kantathavorn, N., Krisorakun, W., Sricharunrat, T., Teerayathanakul, N., Taepisitpong, C., Sornsamdang, G., Krongthong, W., & Saeloo, S. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3241-9 · Cited by 10 · see citing works

Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3‐year follow‐up in an academic institute

Yang, J. Z., Nolte, F., Chajewski, O. S., Lindsey, K., Houser, P. M., Pellicier, J., Wang, Q., & Ehsani, L. (2017) · Diagnostic Cytopathology · doi:10.1002/dc.23843 · Cited by 10 · see citing works

Self- and physician-collected high-risk human papillomavirus (HPV) testing to detect high-grade cervical lesions among Thai women

Phoolcharoen, N., Areeruk, W., Kantathavorn, N., Tiyayon, J., Chittithaworn, S., Wetcho, T., Satitniramai, S., Khomphaiboonkij, U., Pitakkarnkul, S., Termrungruanglert, W., et al. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2023-004424 · Cited by 8 · see citing works

An on-going study of three different cervical cancer screening strategies based on primary healthcare facilities in Beijing China

Han, L., Chang, X., Song, P., Gao, L., Zhang, Y., An, L., & Shen, J. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.09.003 · Cited by 8 · see citing works

Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions

El‐Zein, M., Bouten, S., Abdrabo, L. S., Siblini, A., Louvanto, K., Franco, E. L., & Ferenczy, A. S. (2022) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000706 · Cited by 6 · see citing works

Implementation of primary HPV testing in Japan

Kurokawa, T., Yoshida, Y., Iwanari, O., Oishi, T., KASAI, T., Hamada, M., Fujita, H., Fujiwara, H., Yokoyama, M., Sakuragi, N., et al. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2092 · Cited by 7 · see citing works

Clinical Controversies in Cervical Cancer Screening

Buskwofie, A., CHAN, C., Kahn, R. M., & Holcomb, K. (2019) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000478 · Cited by 6 · see citing works

Clinical efficacy of primary human papillomavirus (HPV) screening with partial genotyping for HPV-16 and HPV-18 subtypes in women from 25 years old

Ang, J. X., Lee, W. Y., & Tay, S. K. (2023) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2022471 · Cited by 4 · see citing works

Disease detection at the 48‐month exit round of the HPV FOCAL cervical cancer screening trial in women per‐protocol eligible for routine screening

Coldman, A. J., van Niekerk, D., Krajden, M., Smith, L., Cook, D. A., Gondara, L., Ceballos, K. M., Quinlan, D. J., Lee, M. H., Elwood‐Martin, R., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32524 · Cited by 3 · see citing works

Impact of HPV Testing Based on the 2020 Update of the German Cervical Cancer Screening Program—Data from a Retrospective Monocentric Study

Jung, L., Klamminger, G. G., Nigdelis, M. P., & Eltze, E. (2025) · Cancers · doi:10.3390/cancers17122024 · Cited by 2 · see citing works

[Effectiveness of Different Testing Strategies Applied for Cervical Cancer Screening in Shuangliu District, Chengdu City].

Zeng, X. R., Li, J., Kang, L., Yan, L.-P., He, Z., Liao, G., Xi, M., & Chen, M.-Y. (2022) · PubMed Central · doi:10.12182/20220960502 · Cited by 2 · see citing works

Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers

Holt, H. K., Kulasingam, S., Sanstead, E. C., Alarid‐Escudero, F., Smith‐McCune, K., Gregorich, S. E., Silverberg, M. J., Huchko, M. J., Kuppermann, M., & Sawaya, G. F. (2020) · MDM Policy & Practice · doi:10.1177/2381468320952409 · Cited by 2 · see citing works

The impact of primary HPV screening on the incidence of cervical cancer in New Zealand

Cox, B., Fitzgerald, P., Austin, R. M., & Sneyd, M. J. (2019) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2019.03.005 · Cited by 2 · see citing works

Prevention – the most effective method of cancer control

Заридзе, Д. Г. (2016) · Practical oncology · doi:10.31917/1704213 · Cited by 2 · see citing works

Changes on the horizon for cervical cancer screening

Isidean, S. D., & Shinder, G. A. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.12.038 · Cited by 2 · see citing works

Autocoleta cervicovaginal no rastreamento do câncer do colo do útero: aceitabilidade, detecção de Papilomavírus Humano de alto risco oncogênico e pesquisa de biomarcadores

Lorenzi, N. P. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-09012020-163231 · Cited by 2 · see citing works

Human Papillomavirus (HPV) Testing on Cervical Cytology Specimens

Guo, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-97397-5_10 · Cited by 1 · see citing works

Cervical cytology and HPV in cervical cancer screening

Bakshi, P., Agarwal, P., & Mangla, G. (2023) · Current Medicine Research and Practice · doi:10.4103/cmrp.cmrp_29_23 · Cited by 2 · see citing works

"HPV Testing as the Primary Tool for Cervical Cancer Screening: Weighing the Benefits and Drawbacks—A Narrative Review"

Patil‐Takbhate, B., Gandham, N. R., & Tripathy, S. P. (2025) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-025-00981-7 · Cited by 1 · see citing works

Comparison of Ex-House and In-House Cytology for the New Cervical Cancer Screening Assessment

Nieberle, L. S., Dietl, A. K., Seibold, A., Brückner, L., Schleicher, O. M., Schulmeyer, C. E., Emons, J., Behrens, A. S., Trnovec, S., Hartmann, A., et al. (2026) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-2900-6511 · Cited by 1 · see citing works

Analysis of the clinical utility of p16/Ki-67 dual staining in screening cervical lesions among women positive for high-risk HPV

Zhang, Q., Lin, Y., Bao, L., & Huang, Q. (2026) · Medicine · doi:10.1097/md.0000000000050102 · Cited by 1 · see citing works

Relationship Between Human Papillomavirus (HPV), Cervical Smear Cytology and Colposcopy Directed Biopsy Results: 4 Year Experience of a University Hospital in Cervical Cancer Screening

Altın, D., & Keskin, D. D. (2022) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · doi:10.38136/jgon.1074012 · Cited by 1 · see citing works

Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study

Gottschlich, A., Hong, Q., Gondara, L., Alam, M. S., Cook, D. A., Martin, R. E., Lee, M. H., Melnikow, J. A., Peacock, S. J., Proctor, L., et al. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-1587 · Cited by 1 · see citing works

Case studies on the progress of cervical cancer screening programs in Bhutan, India, and Türkiye

Burdier, F. R., Bolio, A., Abraham, P., Pimple, S. A., Franco, E. L., Pempa, P., Poljak, M., Gültekin, M., Kjær, S. K., Waheed, D.-E.-N., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.03.012 · Cited by 1 · see citing works

Prueba de concepto de una PCR multiplex de primera generación (cualitativa) para detección del oncogén E7 de VPHS de alto riesgo

Peña-López, B. O., García, L. M. T., Martínez-Vega, R. A., & Rincón‐Orozco, B. (2019) · Revista Investigaciones Andina · doi:10.33132/01248146.1569 · Cited by 1 · see citing works

Effect of Sequential Rounds of Cervical Cancer Screening on Management of HPV-positive Women: A 15-year Population-based Cohort Study from China

Xu, X., Rezhake, R., Hu, S., Chen, F., Zhang, X., Pan, Q., Zhang, W., Ma, J., Qiao, Y., Zhao, F., et al. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0456 · Cited by 1 · see citing works

An Evaluation of the Impact of MR Image Slice Thickness on the Accuracy of High-Dose-Rate Brachytherapy for Gynaecological Cancers

Dubnitzky, L. (2021) · doi:10.32920/ryerson.14644539.v1

An Evaluation of the Impact of MR Image Slice Thickness on the Accuracy of High-Dose-Rate Brachytherapy for Gynaecological Cancers

Dubnitzky, L. (2021) · doi:10.32920/ryerson.14644539

AVANÇOS NO DIAGNÓSTICO MOLECULAR DO PAPILOMA VÍRUS HUMANO E SUA IMPORTÂNCIA CLÍNICA

Fernandes, P. S. (2024) · Revista Contemporânea · doi:10.56083/rcv4n12-261

Trends in Non-Squamous Cervical Cancer Proportion, Histological Type, Stage, Age, and Human Papillomavirus Type in Southwest China from 2009 to 2024: A Large Retrospective StudyPreprint

Sun, L., Qin, Z., Zou, J., Chen, Y., & Zheng, A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5172841

Additional file 3 of Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations

Gates, A., Pillay, J., Reynolds, D., Stirling, R., Traversy, G., Korownyk, C. S., Moore, A. E., Thériault, G., Thombs, B. D., Little, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13514679

Additional file 1 of Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study

Zhao, Y., Bao, H., Ma, L., Bo, S., 狄江丽, Wang, L., Gao, Y., Ren, W., Wang, S., Wang, H.-J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14984922

Additional file 5 of Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations

Gates, A., Pillay, J., Reynolds, D., Stirling, R., Traversy, G., Korownyk, C. S., Moore, A. E., Thériault, G., Thombs, B. D., Little, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13514685

Additional file 6 of Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations

Gates, A., Pillay, J., Reynolds, D., Stirling, R., Traversy, G., Korownyk, C. S., Moore, A. E., Thériault, G., Thombs, B. D., Little, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13514688

Additional file 2 of Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study

Zhao, Y., Bao, H., Ma, L., Song, B., 狄江丽, Wang, L., Gao, Y., Ren, W., Wang, S., Wang, H.-J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14984925

Additional file 2 of Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations

Gates, A., Pillay, J., Reynolds, D., Stirling, R., Traversy, G., Korownyk, C. S., Moore, A. E., Thériault, G., Thombs, B. D., Little, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13514676

Additional file 4 of Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations

Gates, A., Pillay, J., Reynolds, D., Stirling, R., Traversy, G., Korownyk, C. S., Moore, A. E., Thériault, G., Thombs, B. D., Little, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13514682

Additional file 1 of Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations

Gates, A., Pillay, J., Reynolds, D., Stirling, R., Traversy, G., Korownyk, C. S., Moore, A. E., Thériault, G., Thombs, B. D., Little, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13514673

Servikal Preinvaziv Lezyonlara Güncel Yaklaşım

Kayar, İ., Çetin, F., & Birge, Ö. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4064

Impact of the transition to HPV-based primary screening in Portugal's organized cervical cancer screening program: A controlled interrupted time-series analysis (2014-2023)

Sousa, R., Fonseca-Moutinho, J. A., Gomes, F., Loureiro, F., Goes, A. R., & Soares, P. (2026) · Public Health in Practice · doi:10.1016/j.puhip.2026.100792

Invasive Cervical Cancer Detection After Transition to Primary Human Papillomavirus Screening: Population-Based Linkage Study in Portugal

Sousa, R. G., Fonseca-Moutinho, J. A., Gomes, F. S., Loureiro, F., Nascimento, H., Solheiro, H., Saavedra, I., Ponte, M., Barros, M., Pereira, S., et al. (2026) · Acta Médica Portuguesa · doi:10.20344/amp.24709

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study

Ogilvie, G. S., Krajden, M., van Niekerk, D. J., Martin, R. E., Ehlen, T. G., Ceballos, K. M., Smith, L., Kan, L., Cook, D. A., Peacock, S. J., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.489 · Cited by 84 · see citing works

O10.1 Age Specific Round 1 Results of a Cervical Cancer Screening Trial: HPV FOCAL

Ogilvie, G. S., Krajden, M., Ehlen, T. G., Martin, R. E., Smith, L., Peacock, S. J., Stuart, G. C. E., Franco, E. L., & Coldman, A. J. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051184.0137

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial

Coldman, A. J., Gondara, L., Smith, L., van Niekerk, D., Ceballos, K. M., Krajden, M., Cook, D. A., Quinlan, D. J., Lee, M. H., Stuart, G. C. E., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.368 · Cited by 14 · see citing works

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)

Ogilvie, G. S., van Niekerk, D. J., Krajden, M., Martin, R. E., Ehlen, T. G., Ceballos, K. M., Peacock, S. J., Smith, L., Kan, L., Cook, D. A., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-111 · Cited by 84 · see citing works

Primary HPV testing with cytology versus cytology alone in cervical screening—A prospective randomized controlled trial with two rounds of screening in a Chinese population

Chan, K. K. L., Liu, S. S., Wei, N., Ngu, S., Chu, M. M. Y., Tse, K. Y., Lau, L. S. K., Cheung, A., & Ngan, H. (2020) · International Journal of Cancer · doi:10.1002/ijc.32861 · Cited by 26 · see citing works